The invention relates to use of compounds represented by the general formula (I) and pharmaceutically acceptable salts thereof, wherein n is an integer from 2 to 5; p is an integer from 0 to 4; R1 is independently selected from the group consisting of a hydroxyl group, an alkoxy group, a thiol group, and a thioether group, wherein at least two of R1 are on the carbon-2 and carbon-5 positions of the phenyl group; R2 and R3 are independently a methylene group or a nucleophile; Z is an oxygen (O) atom or sulfur (S) atom; and T is hydrogen or an optionally substituted aliphatic group or optionally substituted aryl group; in the manufacture of a medicament for prevention and/or treatment and/or containment of a condition associated with a cell proliferative disorder.
该发明涉及使用由一般式(I)表示的化合物及其在制备与细胞增殖紊乱相关的病症的预防和/或治疗和/或控制药物中的药用盐,其中n是从2到5的整数;p是从0到4的整数;R1是从羟基、烷氧基、
硫醇基和
硫醚基组成的群体中独立选择的,其中至少有两个R1位于苯基的碳-2和碳-5位置;R2和R3分别是亚甲基基团或亲核试剂;Z是氧(O)原子或
硫(S)原子;T是氢或选择性取代的脂肪基团或选择性取代的芳基团。